Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYSB2200179	注射用人干扰素α1b	Recombinant Human Interferon α1b	Lyophilized	Biological Products	Supplementary Application	2022-07-20		view
CYSB2200178	注射用人干扰素α1b	Recombinant Human Interferon α1b	Lyophilized	Biological Products	Supplementary Application	2022-07-20		view
CYSB2200180	注射用人干扰素α1b	Recombinant Human Interferon α1b	Lyophilized	Biological Products	Supplementary Application	2022-07-20		view
CYSB2101195	注射用人干扰素α1b	Recombinant Human Interferon α1b	Lyophilized	Biological Products	Supplementary Application	2021-09-29	Shenzhen Kexing Pharmaceutical Co Ltd	view
CYSB2101196	注射用人干扰素α1b	Recombinant Human Interferon α1b	Lyophilized	Biological Products	Supplementary Application	2021-09-29	Shenzhen Kexing Pharmaceutical Co Ltd	view
CYSB2101198	注射用人干扰素α1b	Recombinant Human Interferon α1b	Lyophilized	Biological Products	Supplementary Application	2021-09-29	Shenzhen Kexing Pharmaceutical Co Ltd	view
CYSB2101197	注射用人干扰素α1b	Recombinant Human Interferon α1b	Lyophilized	Biological Products	Supplementary Application	2021-09-29	Shenzhen Kexing Pharmaceutical Co Ltd	view
CYSB2101193	注射用人干扰素α1b	Recombinant Human Interferon α1b	Lyophilized	Biological Products	Supplementary Application	2021-09-29	Shenzhen Kexing Pharmaceutical Co Ltd	view
CYSB2101194	注射用人干扰素α1b	Recombinant Human Interferon α1b	Lyophilized	Biological Products	Supplementary Application	2021-09-29	Shenzhen Kexing Pharmaceutical Co Ltd	view